Lexicon Pharmaceuticals (LXRX) Net Margin (QoQ) (2010 - 2026)

Lexicon Pharmaceuticals (LXRX) Net Margin (QoQ) (2010 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 Lexicon Pharmaceuticals 1.04 Bn 846.13 Mn 653,000.00

Historic Data

Download Data
DateValue
Jun 30, 2026 -533,677.00
Mar 31, 2026 28,095.00
Dec 31, 2025 -18,838.00
Sep 30, 2025 -10,321.00
Jun 30, 2025 225,552.00
Mar 31, 2025 -213,215.00
Dec 31, 2024 376,247.00
Sep 30, 2024 -40,514.00
Jun 30, 2024 110,513.00
Mar 31, 2024 232,805.00
Dec 31, 2023 3.01 Mn
Sep 30, 2023 -1.94 Mn
Jun 30, 2020 -28.02 Mn
Mar 31, 2020 -24,904.00
Dec 31, 2019 -66,295.00
Sep 30, 2019 282,767.00
Jun 30, 2019 -182,651.00
Mar 31, 2019 -82,588.00
Dec 31, 2018 29,497.00
Sep 30, 2018 -14,175.00